drugset / Trial / NCT02924480

Intravenous Lidocaine for Cystectomy Procedures

NCT02924480 ↗

Completed 50 enrolled CAMC Health System
RandomizedParallel-groupDouble-blindSupportive care

Summary

Patients scheduled for a cystectomy at Charleston Area Medical Center (CAMC) will be enrolled into a randomized, double blinded clinical trial to assess if postoperative pain and ileus are reduced by perioperative intravenous lidocaine infusion versus placebo. The hypothesis is that patients receiving the lidocaine infusion will experience better pain control and ileus resolution. It is believed that lidocaine patients will also have less opioid requirement, less mortality, a shorter length of stay, less nausea /vomiting, and fewer adverse events.

Timeline

Start
2016-10-12
Primary completion
2020-06-17
Completion
2020-06-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous